SALE
市場調查報告書

末梢血單核球(PBMC)的全球市場:至2025年的預測與市場機會

Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 938728
出版日期 內容資訊 英文 117 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

末梢血單核球(PBMC)的全球市場:至2025年的預測與市場機會 Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 117 Pages
簡介

末梢血單核球(PBMC)的全球市場在預測期間內預計將穩定成長。末梢血單核細胞,對於實施生物學及病理學相關的研究,以及癌症相關的臨床研究很重要。再加上PBMC也能利用於致命性疾病,免疫學,疫苗開發等相關的研究。

本報告提供各市場區隔和各地區全球末梢血單核球(PBMC)市場調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球末梢血單核球市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品(凍結保存或冷凍,培養或新鮮,末梢血單核球分離、生存套件)
    • 各用途(免疫學的檢驗,感染疾病,血液學的檢驗,其他)
    • 各技術(密度傾斜離心分離流程,白血球血球分離)
    • 各來源(人,動物)
    • 各企業(2019)
    • 各地區
  • 市場魅力指數

第6章 亞太地區末梢血單核球市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各來源
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第7章 歐洲末梢血單核球市場展望

  • 市場規模與預測
  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各來源
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利

第8章 北美末梢血單核球市場展望

  • 市場規模與預測
  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各來源
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美末梢血單核球市場展望

  • 市場規模與預測
  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各來源
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東及非洲末梢血單核球市場展望

  • 市場規模與預測
  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 各用途
    • 各技術
    • 各來源
    • 各國
  • 市場魅力指數
  • 中東、非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第11章 市場動態

  • 促進因素
  • 阻礙因素

第12章 市場趨勢與趨勢

第13章 臨床試驗

CHAPTER14: 競爭情形環境

  • 競爭預測
  • 主要企業簡介
    • Astarte Biologics, Inc.
    • ATZLabs
    • BioIVT
    • BioLegend, Inc.
    • BioVision
    • Bio-Rad
    • Cell Applications, Inc
    • Celgene
    • Creative Bioarray
    • Dapcel, Inc
    • HemaCare
    • iXCells Biotechnologies
    • Miltenyi Biotec
    • Merck
    • Novo Nordisk
    • Precision Medicine
    • Qiagen NV
    • STEMCELL Technologies Inc.
    • Thermo Fisher Scientific
    • ZenBio, Inc

第15章 策略性推薦

第16章 免責聲明

目錄
Product Code: 4561

The global market for peripheral blood mononuclear cells is expected to grow at a steady CAGR during the forecast period. The peripheral blood mononuclear cells (PBMCs) are crucial to carry out the biology and pathology related studies as well as in clinical research related to cancer. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology by developing economies.

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, company and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the highest market share as they can be used for longer durations of time if stored carefully at lower temperatures.

In terms of regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players of the global peripheral blood mononuclear cells market include Astarte Biologics, Inc., ATZLabs, BioIVT, BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck, Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo Fisher Scientific, ZenBio, Inc., etc. The inter-company competition keeps on increasing parallelly with the market, which in turn leads to innovations in technology, which eventually leading to the growth of the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global peripheral blood mononuclear cells market.
  • To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, company and region.
  • To identify drivers and challenges for global peripheral blood mononuclear cells market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market.
  • To conduct pricing analysis for global peripheral blood mononuclear cells market.
  • To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of research organizations and companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research organizations and companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research organizations and companies, and presence of all major players across the globe.

TechSci Research calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Research Organizations
  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product:

Cryopreserved or Frozen PBMC

Cultured or Fresh PBMC

Peripheral Blood Mononuclear Cell Isolation & Viability Kits

  • Market, By Application:

Immunology

Infectious disease

Hematology

Others

  • Market, By Technique:

Density gradient centrifugation process

Leukapheresis

  • Market, By Source:

Human

Animals

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle east & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Peripheral Blood Mononuclear Cells Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
    • 5.2.2. By Application (Immunology, Infectious disease, Hematology and others)
    • 5.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
    • 5.2.4. By Source (Human, Animals)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technique
    • 6.2.4. By Source
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Product
        • 6.4.1.2.2. By Application
        • 6.4.1.2.3. By Technique
        • 6.4.1.2.4. By Source
    • 6.4.2. India Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Product
        • 6.4.2.2.2. By Application
        • 6.4.2.2.3. By Technique
        • 6.4.2.2.4. By Source
    • 6.4.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Product
        • 6.4.3.2.2. By Application
        • 6.4.3.2.3. By Technique
        • 6.4.3.2.4. By Source
    • 6.4.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Product
        • 6.4.4.2.2. By Application
        • 6.4.4.2.3. By Technique
        • 6.4.4.2.4. By Source
    • 6.4.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Product
        • 6.4.5.2.2. By Application
        • 6.4.5.2.3. By Technique
        • 6.4.5.2.4. By Source
    • 6.4.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Product
        • 6.4.6.2.2. By Application
        • 6.4.6.2.3. By Technique
        • 6.4.6.2.4. By Source

7. Europe Peripheral Blood Mononuclear Cells Market Outlook

  • 7.1. Market Size & Forecast
  • 7.2. Market Size & Forecast
    • 7.2.1. By Value
  • 7.3. Market Share & Forecast
    • 7.3.1. By Product
    • 7.3.2. By Application
    • 7.3.3. By Technique
    • 7.3.4. By Source
    • 7.3.5. By Country
  • 7.4. Market Attractiveness Index
  • 7.5. Europe: Country Analysis
    • 7.5.1. France Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.1.1. Market Size & Forecast
        • 7.5.1.1.1. By Value
      • 7.5.1.2. Market Share & Forecast
        • 7.5.1.2.1. By Product
        • 7.5.1.2.2. By Application
        • 7.5.1.2.3. By Technique
        • 7.5.1.2.4. By Source
    • 7.5.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.2.1. Market Size & Forecast
        • 7.5.2.1.1. By Value
      • 7.5.2.2. Market Share & Forecast
        • 7.5.2.2.1. By Product
        • 7.5.2.2.2. By Application
        • 7.5.2.2.3. By Technique
        • 7.5.2.2.4. By Source
    • 7.5.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.3.1. Market Size & Forecast
        • 7.5.3.1.1. By Value
      • 7.5.3.2. Market Share & Forecast
        • 7.5.3.2.1. By Product
        • 7.5.3.2.2. By Application
        • 7.5.3.2.3. By Technique
        • 7.5.3.2.4. By Source
    • 7.5.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.4.1. Market Size & Forecast
        • 7.5.4.1.1. By Value
      • 7.5.4.2. Market Share & Forecast
        • 7.5.4.2.1. By Product
        • 7.5.4.2.2. By Application
        • 7.5.4.2.3. By Technique
        • 7.5.4.2.4. By Source

8. North America Peripheral Blood Mononuclear Cells Market Outlook

  • 8.1. Market Size & Forecast
  • 8.2. Market Size & Forecast
    • 8.2.1. By Value
  • 8.3. Market Share & Forecast
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By Technique
    • 8.3.4. By Source
    • 8.3.5. By Country
  • 8.4. Market Attractiveness Index
  • 8.5. North America: Country Analysis
    • 8.5.1. United States Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.1.1. Market Size & Forecast
        • 8.5.1.1.1. By Value
      • 8.5.1.2. Market Share & Forecast
        • 8.5.1.2.1. By Product
        • 8.5.1.2.2. By Application
        • 8.5.1.2.3. By Technique
        • 8.5.1.2.4. By Source
    • 8.5.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.2.1. Market Size & Forecast
        • 8.5.2.1.1. By Value
      • 8.5.2.2. Market Share & Forecast
        • 8.5.2.2.1. By Product
        • 8.5.2.2.2. By Application
        • 8.5.2.2.3. By Technique
        • 8.5.2.2.4. By Source
    • 8.5.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.3.1. Market Size & Forecast
        • 8.5.3.1.1. By Value
      • 8.5.3.2. Market Share & Forecast
        • 8.5.3.2.1. By Product
        • 8.5.3.2.2. By Application
        • 8.5.3.2.3. By Technique
        • 8.5.3.2.4. By Source

9. South America Peripheral Blood Mononuclear Cells Market Outlook

  • 9.1. Market Size & Forecast
  • 9.2. Market Size & Forecast
    • 9.2.1. By Value
  • 9.3. Market Share & Forecast
    • 9.3.1. By Product
    • 9.3.2. By Application
    • 9.3.3. By Technique
    • 9.3.4. By Source
    • 9.3.5. By Country
  • 9.4. Market Attractiveness Index
  • 9.5. South America: Country Analysis
    • 9.5.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.1.1. Market Size & Forecast
        • 9.5.1.1.1. By Value
      • 9.5.1.2. Market Share & Forecast
        • 9.5.1.2.1. By Product
        • 9.5.1.2.2. By Application
        • 9.5.1.2.3. By Technique
        • 9.5.1.2.4. By Source
    • 9.5.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.2.1. Market Size & Forecast
        • 9.5.2.1.1. By Value
      • 9.5.2.2. Market Share & Forecast
        • 9.5.2.2.1. By Product
        • 9.5.2.2.2. By Application
        • 9.5.2.2.3. By Technique
        • 9.5.2.2.4. By Source
    • 9.5.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.3.1. Market Size & Forecast
        • 9.5.3.1.1. By Value
      • 9.5.3.2. Market Share & Forecast
        • 9.5.3.2.1. By Product
        • 9.5.3.2.2. By Application
        • 9.5.3.2.3. By Technique
        • 9.5.3.2.4. By Source

10. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook

  • 10.1. Market Size & Forecast
  • 10.2. Market Size & Forecast
    • 10.2.1. By Value
  • 10.3. Market Share & Forecast
    • 10.3.1. By Product
    • 10.3.2. By Application
    • 10.3.3. By Technique
    • 10.3.4. By Source
    • 10.3.5. By Country
  • 10.4. Market Attractiveness Index
  • 10.5. MEA: Country Analysis
    • 10.5.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.1.1. Market Size & Forecast
        • 10.5.1.1.1. By Value
      • 10.5.1.2. Market Share & Forecast
        • 10.5.1.2.1. By Product
        • 10.5.1.2.2. By Application
        • 10.5.1.2.3. By Technique
        • 10.5.1.2.4. By Source
    • 10.5.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.2.1. Market Size & Forecast
        • 10.5.2.1.1. By Value
      • 10.5.2.2. Market Share & Forecast
        • 10.5.2.2.1. By Product
        • 10.5.2.2.2. By Application
        • 10.5.2.2.3. By Technique
        • 10.5.2.2.4. By Source
    • 10.5.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.3.1. Market Size & Forecast
        • 10.5.3.1.1. By Value
      • 10.5.3.2. Market Share & Forecast
        • 10.5.3.2.1. By Product
        • 10.5.3.2.2. By Application
        • 10.5.3.2.3. By Technique
        • 10.5.3.2.4. By Source

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Clinical Trials

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Astarte Biologics, Inc.
    • 14.2.2. ATZLabs
    • 14.2.3. BioIVT
    • 14.2.4. BioLegend, Inc.
    • 14.2.5. BioVision
    • 14.2.6. Bio-Rad
    • 14.2.7. Cell Applications, Inc
    • 14.2.8. Celgene
    • 14.2.9. Creative Bioarray
    • 14.2.10. Dapcel, Inc
    • 14.2.11. HemaCare
    • 14.2.12. iXCells Biotechnologies
    • 14.2.13. Miltenyi Biotec
    • 14.2.14. Merck
    • 14.2.15. Novo Nordisk
    • 14.2.16. Precision Medicine
    • 14.2.17. Qiagen NV
    • 14.2.18. STEMCELL Technologies Inc.
    • 14.2.19. Thermo Fisher Scientific
    • 14.2.20. ZenBio, Inc

15. Strategic Recommendation

16. About Us & Disclaimer